サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1547487

全ゲノム増幅の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Whole Genome Amplification Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 170 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
全ゲノム増幅の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 170 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

全ゲノム増幅市場の世界需要は、調査期間2024～2032年のCAGR 8.44%で、2023年の341万米ドルから2032年には約707万米ドルの市場規模に達すると推定されます。

全ゲノム増幅（WGA）は、ゲノム全体を増幅するプロセスです。プロセス開始時にはナノグラムにとどまっていたDNA量が、マイクログラムの増幅産物に変換されます。これはポリメラーゼ連鎖反応の原理に基づいており、酵素的にゲノム標本からDNAを複製します。WGAは、少量のゲノムDNAの助けを借りて、限られたDNA標本の数を増加させるので、重要なツールと考えられています。WGAは生物の遺伝子を研究するのに非常に有用であり、保存された限られた標本で行われます。この手順は、多くの用途で広く使用されています。

市場力学

様々なセグメントで全ゲノム増幅の応用が増加していることが、WGA市場を牽引する主要因です。遺伝性疾患や胚性疾患の診断、ジェノタイピング、法医学、古いDNAサンプルの分析など、WGAの利用が増加していることから、WGAは良好な成長が見込まれています。さらに、WGAに関する認知度の向上、臨床試験のための多額の投資、分子生物学への応用がWGA市場の成長に寄与します。しかし、WGAの結果がPCR WGAとREPLI-gという2つの異なる技術、すなわちDNAの配列決定、増幅、抽出に使用される技術によって異なる可能性があるという事実は、おそらく市場成長の妨げになると考えられます。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、全ゲノム増幅の世界市場における各セグメントを包括的に評価することもできます。全ゲノム増幅産業の成長と動向は、この調査に全体的なアプローチを記載しています。

市場セグメンテーション

全ゲノム増幅市場レポートのこのセクションは、国と地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家が今後の機会でそれぞれの製品やサービスの対象層を特定するのに役立ちます。

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける全ゲノム増幅市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、本レポートでは、著名な全地域にわたる個々の用途セグメントの需要、推定・予測に焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 全ゲノム増幅-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 全ゲノム増幅の世界市場分析：タイプ別

  • タイプ別概要
  • タイプ別過去・予測データ分析
  • シングルセルWGAキット
  • 完全WGAキット
  • WGA再増幅キット
  • WGA＆チップDNAキット
  • その他

第6章 全ゲノム増幅の世界市場分析：用途別

  • 用途別概要
  • 用途別過去・予測データ分析
  • 創薬・医薬品開発
  • 疾病診断
  • 農業・獣医療
  • 研究
  • 科学捜査
  • その他

第7章 全ゲノム増幅の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • エンドユーザー別過去・予測データ分析
  • 製薬・バイオテクノロジー企業
  • 委託研究
  • 病院・クリニック
  • 研究・学術機関
  • 団体
  • その他

第8章 全ゲノム増幅の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第9章 全ゲノム増幅企業の競合情勢

  • 全ゲノム増幅市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品の上市
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Qiagen NV
  • LGC Group
  • Sigma-Aldrich
  • GE Healthcare
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Single Cell WGA Kit Market Sales By Geography (USD MN)
  • Complete WGA Kit Market Sales By Geography (USD MN)
  • WGA Reamplification Kit Market Sales By Geography (USD MN)
  • WGA & Chip DNA Kit Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Drug Discovery & Development Market Sales By Geography (USD MN)
  • Disease Diagnosis Market Sales By Geography (USD MN)
  • Agriculture & Veterinary Market Sales By Geography (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Forensics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Pharmaceutical & Biotech Companies Market Sales By Geography (USD MN)
  • Contract Research Market Sales By Geography (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Research & Academic Institutes Market Sales By Geography (USD MN)
  • Organizations Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Whole Genome Amplification Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Whole Genome Amplification Report
  • Market Research Process
  • Market Research Methodology
  • Global Whole Genome Amplification Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Single Cell WGA Kit Market Sales By Geography (USD MN)
  • Complete WGA Kit Market Sales By Geography (USD MN)
  • WGA Reamplification Kit Market Sales By Geography (USD MN)
  • WGA & Chip DNA Kit Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Drug Discovery & Development Market Sales By Geography (USD MN)
  • Disease Diagnosis Market Sales By Geography (USD MN)
  • Agriculture & Veterinary Market Sales By Geography (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Forensics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Pharmaceutical & Biotech Companies Market Sales By Geography (USD MN)
  • Contract Research Market Sales By Geography (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Research & Academic Institutes Market Sales By Geography (USD MN)
  • Organizations Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11215177

The global demand for Whole Genome Amplification Market is presumed to reach the market size of nearly USD 7.07 Million by 2032 from USD 3.41 Million in 2023 with a CAGR of 8.44% under the study period 2024-2032.

Whole-genome amplification (WGA) is a process where an entire genome gets amplified. The quantity of DNA which remains in nanograms at the beginning of the process gets converted into micrograms of amplified products. It works on the principles of polymerase chain reaction, which enzymatically replicates the DNA from the genome specimen. WGA is considered an important tool as it increases the limited number of DNA specimens with the help of a small quantity of genomic DNA. It is very useful for studying the gene of an organism, which is done with the conserved limited specimen. This procedure is widely used in a number of applications.

MARKET DYNAMICS

The increasing application of whole genome amplification in various fields is a key factor driving the WGA market. The WGA is expected to witness favorable growth owing to the increasing use of WGA for diagnosing genetic disorders and embryonic disorders, genotyping, forensic, and analysis of old DNA samples. Furthermore, increasing awareness about WGA, a considerable amount of investment for clinical trials and application in molecular biology will contribute to WGA market growth. However, the fact that the result of WGA may vary with two different technologies, namely PCR WGA and REPLI-g, used for sequencing, amplifying, and extracting DNA, will probably hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Whole Genome Amplification. The growth and trends of Whole Genome Amplification industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Whole Genome Amplification market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Single Cell WGA Kit
  • Complete WGA Kit
  • WGA Reamplification Kit
  • WGA & Chip DNA Kit
  • Others

By Application

  • Drug Discovery & Development
  • Disease Diagnosis
  • Agriculture & Veterinary
  • Research
  • Forensics
  • Others

By End-User

  • Pharmaceutical & Biotech Companies
  • Contract Research
  • Hospitals & Clinics
  • Research & Academic Institutes
  • Organizations
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Whole Genome Amplification market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Whole Genome Amplification market include Qiagen NV, LGC Group, Sigma-Aldrich, GE Healthcare. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. WHOLE GENOME AMPLIFICATION - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-User
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL WHOLE GENOME AMPLIFICATION MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. Single Cell WGA Kit Historic and Forecast Sales By Regions
  • 5.4. Complete WGA Kit Historic and Forecast Sales By Regions
  • 5.5. WGA Reamplification Kit Historic and Forecast Sales By Regions
  • 5.6. WGA & Chip DNA Kit Historic and Forecast Sales By Regions
  • 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL WHOLE GENOME AMPLIFICATION MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Drug Discovery & Development Historic and Forecast Sales By Regions
  • 6.4. Disease Diagnosis Historic and Forecast Sales By Regions
  • 6.5. Agriculture & Veterinary Historic and Forecast Sales By Regions
  • 6.6. Research Historic and Forecast Sales By Regions
  • 6.7. Forensics Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL WHOLE GENOME AMPLIFICATION MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-User
  • 7.2. Historical and Forecast Data Analysis By End-User
  • 7.3. Pharmaceutical & Biotech Companies Historic and Forecast Sales By Regions
  • 7.4. Contract Research Historic and Forecast Sales By Regions
  • 7.5. Hospitals & Clinics Historic and Forecast Sales By Regions
  • 7.6. Research & Academic Institutes Historic and Forecast Sales By Regions
  • 7.7. Organizations Historic and Forecast Sales By Regions
  • 7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL WHOLE GENOME AMPLIFICATION MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE WHOLE GENOME AMPLIFICATION COMPANIES

  • 9.1. Whole Genome Amplification Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF WHOLE GENOME AMPLIFICATION INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Qiagen NV
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. LGC Group
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Sigma-Aldrich
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. GE Healthcare
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies